Use of CRISPR-CAS9 to reduce levels of mutant huntingtin and mitochondrial dysfunction in an in vitro model of Huntington’s disease

N Kolli; Gary Dunbar

Use of CRISPR-CAS9 to reduce levels of mutant huntingtin and mitochondrial dysfunction in an in vitro model of Huntington’s disease

Research output: Contribution to conference › Poster › peer-review

Original language	English
State	Published - Aug 2018
Event	Eleventh Biennial Symposium of the Hereditary Disease Foundation - Cambridge, MA Duration: Aug 1 2018 → Aug 31 2018

Other

Other	Eleventh Biennial Symposium of the Hereditary Disease Foundation
Period	08/1/18 → 08/31/18

Cite this

@conference{9d7f918990064bf1ae3ef77dce274520,

title = "Use of CRISPR-CAS9 to reduce levels of mutant huntingtin and mitochondrial dysfunction in an in vitro model of Huntington{\textquoteright}s disease",

author = "N Kolli and Gary Dunbar",

year = "2018",

month = aug,

language = "English",

note = "Eleventh Biennial Symposium of the Hereditary Disease Foundation ; Conference date: 01-08-2018 Through 31-08-2018",

}

Use of CRISPR-CAS9 to reduce levels of mutant huntingtin and mitochondrial dysfunction in an in vitro model of Huntington’s disease

Other

Fingerprint

Cite this